Joincare Pharmaceutical Group Industry Co., Ltd. Class ASSE: 600380

Announcement on Obtaining Notice of Approval for Drug Clinical Trials of TSLP Monoclonal Antibody for New Indication

· Issued by Joincare Pharmaceutical Group Industry Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining Notice of Approval for Drug Clinical Trials of TSLP Monoclonal Antibody for New Indication

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis